EGFR and neoplasm: Another main feature of Notch3 signaling is to induce tumor resistance against several kinds of chemotherapeutic drugs, including doxorubicin, platinum, taxane, epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors (TKIs) and gemcitabine (See in Notch3 and Drug Resistance).